UBS Group AG - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$124,826
-10.7%
35,973
+19.7%
0.00%
Q2 2023$139,798
-63.4%
30,064
-63.6%
0.00%
Q1 2023$382,074
-34.9%
82,700
+13.8%
0.00%
Q4 2022$587,117
+9685.3%
72,663
+6659.3%
0.00%
Q3 2022$6,000
-68.4%
1,075
-71.1%
0.00%
Q2 2022$19,000
-97.9%
3,723
-96.6%
0.00%
Q1 2022$907,000
+3843.5%
110,333
+8936.3%
0.00%
Q3 2021$23,000
+91.7%
1,221
+140.8%
0.00%
Q1 2021$12,000
+50.0%
507
-32.6%
0.00%
Q3 2020$8,000
-81.0%
752
-86.0%
0.00%
Q2 2020$42,000
-38.2%
5,375
-18.9%
0.00%
Q1 2020$68,000
-54.1%
6,628
-50.8%
0.00%
Q4 2019$148,000
+87.3%
13,464
+54.9%
0.00%
Q3 2019$79,000
+259.1%
8,690
+341.1%
0.00%
Q2 2019$22,000
-35.3%
1,970
-47.6%
0.00%
Q4 2018$34,000
+78.9%
3,758
+201.1%
0.00%
Q3 2018$19,0001,2480.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders